Critical Care

official impact factor 4.60

This article is part of the supplement: Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma

Highly Access

Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings

R Michael Grounds* and Charles Bolan

Critical Care 2005, 9(Suppl 5):S29-S36 doi:10.1186/cc3783

Accesses  

  • Last 30 days: 25 accesses
  • Last year: 410 accesses
  • All time: 8133 accesses

Cited by

BioMed Central: 1 citation

Correction   Free

Correction: Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings

R Michael Grounds, Charles Bolan Critical Care 2005, 9:560 (4 November 2005)